US FDA approval was received on September 1 for 4DMedical's lung-imaging technology, CT:VQ, the world's first and only non-contrast, CT-based ventilation-perfusion imaging technology. This FDA clearance was described as "a historic moment in respiratory diagnostics" 4DMedical (4DX), founded by radiologist Andreas Fouras, has developed a patented lung imaging platform that uses X-ray technology and proprietary algorithms to create functional four-dimensional scans. The company can diagnose respiratory conditions earlier, faster, and with more precision than traditional CT scans, and is on the cusp of revolutionising respiratory diagnostics. The company's flagship product,...